Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
54.2%
% of PPH's 27 holdings also in FTXH
26.0%
% of FTXH's 51 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 6.6% | 7.5% | 6.6% |
|
ABBVIE INC | 6.5% | 7.4% | 6.5% |
|
MERCK & CO. INC. | 4.8% | 7.3% | 4.8% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% | 7.6% | 4.5% |
|
PFIZER INC | 4.4% | 7.2% | 4.4% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to FTXH
|
ELI LILLY & CO | 8.5% |
 |
NOVARTIS AG-ADR | 5.2% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.9% |
|
CENCORA INC | 4.9% |
 |
SANOFI-AVENTIS-ADR | 4.9% |
|
MCKESSON CORP | 4.7% |
 |
NOVO-NORDISK A/S-SPONS ADR | 4.7% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.5% |
 |
TEVA PHARMACEUTICAL-SP ADR | 4.1% |
PPH Underweight Relative to FTXH
|
AMGEN INC | -3.7% |
|
BIOGEN IDEC INC | -3.7% |
|
GILEAD SCIENCES INC | -3.7% |
|
UNITED THERAPEUTICS CORP | -3.6% |
|
REGENERON PHARMACEUTICALS | -3.4% |
|
BRISTOL-MYERS SQUIBB CO | -3.0% |
|
PFIZER INC | -2.7% |
|
MERCK & CO. INC. | -2.5% |
|
CHARLES RIVER LABORATORIES | -2.0% |
|
EXELIXIS INC | -1.9% |